Results 31 to 40 of about 995 (171)

Nutritional considerations for the management of equine pituitary pars intermedia dysfunction

Equine Veterinary Education, 2023
Summary Pituitary pars intermedia dysfunction (PPID) is a common endocrine disorder affecting equids.
Nicolas C Galinelli, Simon R Bailey, Nicholas J Bamford   +2 more
exaly   +2 more sources

Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses. [PDF]

J Vet Intern Med, 2015
Background: Paired measurement of ACTH concentration may be more reliable than a single measurement.<p></p> Hypothesis/Objectives To determine whether the mean of 2 measurements of ACTH concentration is more reliable in assessing ...
Rendle DI, Duz M, Beech J, Parkin T, Durham AE.   +4 more
europepmc   +2 more sources

Pituitary pars intermedia dysfunction (Cushing’s syndrome) associated with pituitary adenoma in a mare

Acta Veterinaria Brasilica
Pituitary pars intermedia dysfunction (PPID), also known as Cushing’s syndrome (CS) or hyperadrenocorticism, is a condition characterized by loss of dopaminergic inhibition of the pituitary pars intermedia.
Schorn , Isabela, Paula Maurique Pereira, Ana, Leite dos Anjos, Bruno, da Silva Azevedo , Marcos, Damasceno Nunes dos Santos, Matheus, Camargo Góss, Geórgia, Paula Da Costa Rodrigues, Ana   +6 more
core   +2 more sources

Development of a health-related quality-of-life assessment tool for equines with pituitary pars intermedia dysfunction. [PDF]

Equine Vet J
Abstract Background Clinical signs of pituitary pars intermedia dysfunction (PPID) are frequently mistaken for ‘normal’ ageing and may not be optimally assessed. Objective quality of life (QoL) assessment could improve clinical decision‐making. Objectives To develop an owner‐reported health‐related quality‐of‐life (HRQoL) assessment tool for equines ...
Bouquet A, Nicol C, Knowles EJ, Schofield I, Menzies-Gow NJ.   +4 more
europepmc   +2 more sources

Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction. [PDF]

Equine Vet J
Abstract Background Due to the high frequency of laminitis reported for both conditions, the relationship between pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID), and the potential role of dopamine in modifying insulin secretion, requires further investigation.
Galinelli NC, Bamford NJ, Erdody ML, Mackenzie SA, Warnken T, Harris PA, Sillence MN, Bailey SR.   +7 more
europepmc   +2 more sources

Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review

The Veterinary Journal, 2020
Pergolide, a dopamine agonist, is commonly administered to manage pituitary pars intermedia dysfunction (PPID), a progressive neurodegenerative disease prevalent in aged horses.
Tatum, RC, Ireland, JL, McGowan, CM
core   +3 more sources

Lymphocytic hypophysitis in dogs infected with Leishmania spp.

Frontiers in Veterinary Science, 2023
BackgroundMorphological involvement of endocrine glands, such as the pituitary gland, remain uninvestigated in dogs with canine visceral leishmaniasis. Therefore, this study investigated the presence of amastigotes of Leishmania spp.
Edenilson Doná Frigerio, Cecilia de Castro Guizelini, Giulia Gonçalves Jussiani, Karen Santos Março, Guilherme Dias de Melo, Tatiane Terumi Negrão Watanabe, Gisele Fabrino Machado   +6 more
doaj   +1 more source

Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses

Animals, 2022
Pituitary pars intermedia dysfunction (PPID) is diagnosed by increased basal or post thyrotropin-releasing hormone (TRH) stimulation ACTH concentrations.
Sophia L. Hinrichsen, Ka Y. Yuen, Elizabeth L. Dryburgh, François-René Bertin, Allison J. Stewart   +4 more
doaj   +1 more source

Potential Neuroprotection for Equine Pituitary Pars Intermedia Dysfunction

The FASEB Journal, 2021
Cushing's disease, known as pituitary pars intermedia dysfunction (PPID), is the most commonly diagnosed equine endocrinopathy. Compelling evidence suggests that alpha‐synuclein, an abundant neuronal protein, can acquire a neurotoxic feature that kills dopamine secreting nerve cells in horse afflicted with PPID.
Ashley Hetak, Jessica Fortin
openaire   +1 more source

Influence of endocrine disease on l‐lactate concentrations in blood of ponies

Journal of Veterinary Internal Medicine, 2021
Background Blood l‐lactate concentrations are higher in people with developing or established diabetes mellitus and insulin resistance. Objectives To investigate whether blood l‐lactate concentrations are positively correlated with measures of insulin ...
Bettina Dunkel, Edward J. Knowles, Yu‐Mei Chang, Nicola J. Menzies‐Gow   +3 more
doaj   +1 more source